Abstract |
Mollugin, a bioactive phytochemical isolated from Rubia cordifolia L., has shown preclinical anticancer efficacy in various cancer models. However the effects of mollugin in regulating cancer cell survival and death remains undefined. In the present study we found that mollugin exhibited cytotoxicity on various cancer models. The suppression of cell viability was due to the induction of mitochondria apoptosis. In addition, the presence of autophagic hallmarks was observed in mollugin-treated cells. Notably, blockade of autophagy by a chemical inhibitor or RNA interference enhanced the cytotoxicity of mollugin. Further experiments demonstrated that phosphatidylinositide 3- kinases/protein kinase B/ mammalian target of rapamycin/p70S6 kinase (PI3K/AKT/mTOR/ p70S6K) and extracellular regulated protein kinases (ERK) signaling pathways participated in mollugin-induced autophagy and apoptosis. Together, these findings support further studies of mollugin as candidate for treatment of human cancer cells.
|
Authors | Li Zhang, Handong Wang, Jianhong Zhu, Jianguo Xu, Ke Ding |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 450
Issue 1
Pg. 247-54
(Jul 18 2014)
ISSN: 1090-2104 [Electronic] United States |
PMID | 24887566
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 Elsevier Inc. All rights reserved. |
Chemical References |
- Drugs, Chinese Herbal
- Pyrans
- rubimaillin
- MTOR protein, human
- Proto-Oncogene Proteins c-akt
- Ribosomal Protein S6 Kinases, 70-kDa
- TOR Serine-Threonine Kinases
|
Topics |
- Animals
- Cell Death
(drug effects)
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Drugs, Chinese Herbal
(administration & dosage)
- Humans
- MAP Kinase Signaling System
(drug effects)
- Mice
- Neoplasms, Experimental
(metabolism, pathology)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Pyrans
(administration & dosage)
- Ribosomal Protein S6 Kinases, 70-kDa
(metabolism)
- TOR Serine-Threonine Kinases
(metabolism)
|